Background {#Sec1}
==========

The American Society of Anesthesiologists Physical Status Classification system (ASA-PS) is a commonly used, subjective method to categorize patients' fitness for surgery \[[@CR1], [@CR2]\]. Originally developed by Saklad et al., the six-point classification system ranges from healthy patients with no comorbidities (ASA-PS 1) to brain-dead patients whose organs are being removed for donor purposes (ASA-PS 6) \[[@CR3]\]. Though the system was initiated more than 5 decades ago, the scoring system continues to perform fairly well in assessing patients for both inpatient and outpatient surgery \[[@CR4]\].

While the original intent of the ASA-PS was to stratify severity of illness prior to surgery, more recently the ASA-PS has been used as a simple means to predict outcomes \[[@CR5]--[@CR7]\]. While other and potentially better surgical outcome prediction methods are available, most have been developed for specific surgical conditions rather than for 'surgery' in general \[[@CR8]\]. The ASA-PS has face validity as an assessment of functional capacity, which is increasingly thought to be a significant predictor of patient outcome \[[@CR9]\]. ASA-PS is now included within risk-adjustment algorithms comparing hospital performance in surgical care i.e., the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) \[[@CR10]\]. Models drawn entirely from preoperative NSQIP data may also be particularly helpful in risk stratification during the preoperative evaluation process \[[@CR7], [@CR11], [@CR12]\].

Though the ASA-PS has validity as a marker of patients' preoperative health status, multiple studies nevertheless have found that inter-rater reliability is moderate, meaning different anesthesiologists often give the same patient different classification levels \[[@CR2], [@CR13], [@CR14]\]. Studies also indicate that ASA-PS may be missing or misclassified in data registries, which can lead to miscalculations of outcomes benchmarking for facilities \[[@CR15], [@CR16]\]. Most concerning are ASA-PS scores that are far from their expected value given observed patient characteristics -- for example a patient with a ASA-PS IV but no recorded comorbidities. While ASA-PS as recorded in clinical databases may have measurement errors, an automated, risk model-derived calculation of ASA-PS that takes into account multiple aspects of the patients condition can serve as an initial proxy for improving and evaluating quality of care. The automated, risk model-derived ASA-PS may suggest more accurate initial values or corrections to these errors. Accordingly, the objectives of this study were to 1) develop and internally cross-validate a predictive model for ASA-PS using a wide range of preoperative predictors; and 2) assess the concurrent and predictive validity of the model by assessing associations between predicted ASA-PS, observed ASA-PS, and a diverse set of 30-day outcomes.

Methods {#Sec2}
=======

Data sources {#Sec3}
------------

We used de-identified registry data; therefore, the study was exempt from IRB review. Our data source was the 2014 Participant Use File (PUF) of the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP), which is available to member institutions \[[@CR17]\]. The ACS-NSQIP collects data on over 150 variables, including preoperative risk factors, ASA-PS, intraoperative variables, and 30-day postoperative mortality and morbidity outcomes for patients undergoing major surgical procedures in both the inpatient and outpatient surgical setting. Definitions for the variables are found within the PUF file.

Development of analytic sample {#Sec4}
------------------------------

From the 750,937 surgeries represented in the 2014 PUF(Fig. [1](#Fig1){ref-type="fig"}), we excluded procedures that met any of the following criteria: emergent or non-elective surgeries; surgeries for patients transferred to the hospital (not admitted from home); patients \< 18 years old or ≥ 90 years old at the time of surgery; procedures for patients who were inpatients immediately prior to their index surgery; surgeries for patients who had missing ASA assignment or had a ASA-PS class of '5-Moribund'; and procedures of patients who had incomplete data for any of the predictors identified for model development (see below). We selected these criteria given evidence of lower inter-rater agreement for ASA-PS for emergent cases or at extremes of age \[[@CR14]\]. In addition, in trauma surgery, interrater reliability for assigning ASA-PS is fair at best and complete information on preoperative variables may be missing \[[@CR18]\]. Fig. 1Flowchart of Cohort Inclusion and Exclusion Criteria

Development and internal validation of a model to predict ASA-PS {#Sec5}
----------------------------------------------------------------

### Outcome {#Sec6}

Clinical assignment of ASA-PS status as represented in the 2014 NSQIP PUF on a scale from 1 to 4 (Table [1](#Tab1){ref-type="table"}). Table 1Current Definitions and Examples of American Society of Anesthesiologists Physical Status (ASA-PS) ClassASA Physical Status ClassificationDefinitionExamples, including, but not limited to:ASA-PS IA normal healthy patientHealthy, non-smoking, no or minimal alcohol useASA-PS IIA patient with mild systemic diseaseMild diseases only without substantive functional limitations.Mild diseases only without substantive functional limitations. Examples include (but not limited to): current smoker, social alcohol drinker, pregnancy, obesity (30 \< BMI \< 40), well-controlled DM/HTN, mild lung diseaseASA-PS IIIA patient with severe systemic diseaseSubstantive functional limitations; One or more moderate to severe diseases. Examples include (but not limited to): poorly controlled DM or HTN, COPD, morbid obesity (BMI ≥40), active hepatitis, Alcohol dependence or abuse, implanted pacemaker, moderate reduction in ejection fraction, ESRD undergoing regularly scheduled dialysis, premature infant PCA \< 60 weeks, history (\> 3 months) of MI, CVA, TIA, or CAD/stents.ASA-PS IVA patient with severe systemic disease that is a constant threat to lifeRecent (\<  3 months) history of MI, CVA, TIA, or CAD/stents. Ongoing cardiac ischemia or severe valve dysfunction, severe reduction of ejection fraction, sepsis, DIC, ARD or ESRD not undergoing regularly scheduled dialysisASA-PS VA moribund patient who is not expected to survive without the operationRuptured abdominal/thoracic aneurysm, massive trauma, intracranial bleed with mass effect, ischemic bowel in the face of significant cardiac pathology or multiple organ/system dysfunctionASA-PS VIA declared brain-dead patient whose organs are being removed for donor purposesAvailable at [www.asahq.org/resources/clinical-information/asa-physical-status-classification-system](http://www.asahq.org/resources/clinical-information/asa-physical-status-classification-system); The addition of "E" denotes emergency surgery: (An emergency is defined as existing when delay in treatment of the patient would lead to a significant increase in the threat to life or body part)

### Predictors {#Sec7}

We identified predictors that would be commonly available during preoperative evaluation such as demographics, codes indicative of common diagnoses and treatments, and functional status before surgery. We also evaluated preoperative laboratory data (i.e., pre-operative serum sodium) as potential predictors and noted that they were missing for a large proportion of cases, most likely not at random; and so did not include them in our final model. Sex: Defined as either male or femaleRace/Ethnicity: Defined with 6 categories: non-Hispanic White; non-Hispanic Black; Hispanic; non-Hispanic Asian; non-Hispanic Other; UnknownAge: Age of patient (18--89 yrs)Body mass index (BMI): Defined by height and weight by the following formula; (703 x wt (lbs) / (ht (in)) ^2^Diagnoses and Treatments: ◦ diabetes (None, insulin dependent; non-insulin dependent);◦ hypertension required medication (yes, no; The patient must have been receiving or required long-term treatment of their chronic hypertension for \> 2 weeks.);◦ chronic obstructive pulmonary disease (yes, no);◦ congestive heart failure (yes, no);◦ renal failure (yes, no);◦ disseminated cancer (yes, no);◦ smoker (yes, no);◦ sepsis (none vs. any sepsis; septic shock; or systemic inflammatory response syndrome (SIRS);◦ ascites (yes, no);◦ preoperative wound infection (yes, no);◦ weight loss (yes, no);◦ bleeding disorders (yes, no);◦ dyspnea (none; at rest; or with moderate exertion);◦ the presence of mechanical ventilation greater than 48 h prior to surgery (yes, no);◦ smoking status prior to surgery (yes, no);◦ bleeding prior to surgery (yes, no),◦ dialysis (yes, no);◦ steroid use (yes, no);◦ transfusion (yes, no);◦ functional status before surgery (independent; partially dependent; totally dependent to perform activities of daily living \[ADLs\] in the 30 days prior to surgery).

### Statistical analysis {#Sec8}

Multinomial logistic regression was fitted on our final sample using ASA-PS as the outcome and variables listed above as predictors. The model was fitted using 'nnet' package built in R 3.3.0 \[[@CR19]\]. We internally validated the model performance using 10-fold cross-validation. The C-statistic, an index of model accuracy, was calculated as the mean across the 10 repetitions. The C-Statistic can be defined as the probability that a person who has been clinically assigned to a specific ASA classification has a higher predicted probability of being in that class than someone with a different classification \[[@CR20], [@CR21]\]. The C-statistic and its corresponding 95% CI was calculated using the 'pROC' package in R. We compared the concurrent validity of predicted vs. observed ASA-PS (i.e., patients with predicted ASA-PS \> observed ASA-PS vs. those with observed ASA-PS \> predicted ASA-PS) by examining group associations with BMI, comorbidities, and functional status using two-sample Wilcoxon rank-sum (Mann-Whitney) tests.

Assessing the predictive validity of the ASA-PS model {#Sec9}
-----------------------------------------------------

### Outcomes {#Sec10}

As defined in the ACS-NSQIP PUF, 30-day postoperative complications included the following binary (yes/no) outcome variables: mortality; and morbidity: venous thromboembolism; deep incisional surgical site infection; cardiac complications \[myocardial infarction\], cerebrovascular accident; respiratory complications \[respiratory failure\]; wound infections; sepsis; returned to the OR; renal insufficiency; and any complication.

### Predictors {#Sec11}

Coefficients from the multinomial logistical regression were used to predict the probabilities of each ASA-PS class (1-no disturbance, 2-mild, 3-severe, 4-life threat) for each person in the sample. We then assigned an ASA-PS class to each person based on their highest predicted probability (the class most likely) outputted from the model. In addition to the predicted ASA score, the following potential intraoperative confounders were included: Current Procedural Terminology (CPT) body system group (primary procedure codes were classified by major organ system type i.e., gastrointestinal, musculoskeletal etc., using Clinical Classification Software \[CCS\] systems); wound classification (clean/contaminated; contaminated; dirty/infected); anesthesia type (general anesthesia; spinal; epidural; monitored anesthesia care (MAC); or unknown); hospital length of stay in days; and operative time (total operative duration in hours) \[[@CR22]\].

### Statistical analysis {#Sec12}

To compare the predictive power of observed vs. predicted ASA class, we first conducted separate logistic regressions using either as the independent variable and each 30-day postoperative complication as the outcome. C-statistics and the corresponding bootstrapped 95% CI in each model were calculated and compared by the two ASA class types in parallel. In addition, we compared the C-statistics for each outcome adjusting for important intraoperative variables such as CPT body system group, wound classification, anesthesia type, hospital length of stay and operation type. We then further evaluated the predictive validity of our model by conducting a patient-level pairwise analysis i.e., a contingency table of predicted ASA-PS vs. observed ASA-PS for each outcome (presence vs. absence).

We used SAS software, version 9.24 (SAS Institute Inc., Cary, NC, USA) and R software, version 3.0.2 (<https://www.r-project.org/>) for the statistical analyses, online tool development and graphics. To aid further research and use of the ASA-PS model, we implemented an online calculator using Shiny \[[@CR23]\].

Results {#Sec13}
=======

Sample characteristics {#Sec14}
----------------------

Our final analytical dataset included a total of 566,797 elective procedures (Fig. [1](#Fig1){ref-type="fig"} and Table [2](#Tab2){ref-type="table"}). Overall, most of the patients (88%) were ASA-PS 2 (48.9%) or 3 (39.1%), followed by ASA 1 (8.9%) and ASA 4 (3.2%). On average, the patients were in their mid-50s. The majority were female, obese (class I), predominantly white, mostly non-diabetic, hypertension requiring medications, with about one-fifth being smokers. Most of the patients did [not]{.ul} have a diagnosis of COPD, CHF, renal failure, disseminated cancer, ascites, wound infections, weight loss, require transfusions, or having been on a ventilator.

Table [3](#Tab3){ref-type="table"} provides the most frequent procedures by CPT-body system classification and Top 20 level-one CCS (mapped by CPT) codes. The majority of patients had a digestive or musculoskeletal system procedure, though there were representative procedures across all other organ systems. The most frequent specific surgeries included those classified as other, hernia repairs, hysterectomy, and colorectal resections. Table 2Characteristics of Study SampleAllASA-PS ^a^1ASA-PS 2ASA-PS 3ASA-PS 4*N* = 566,79750,2858.9%277,15648.9%221,45339.1%17,9033.2%AvgsdAvgsdAvgsdAvgsdAvgsdAge55.915.640.514.153.514.861.713.866.512.6BMI30.57.726.54.829.56.432.78.831.29.5no.%no.%no.%no.%no.%*n=*566,79750,2858.9%277,15648.9%221,45339.1%17,9033.2%Sex Female329,66958.2%28,28856.3%171,51261.9%122,62455.4%724540.5% Male237,12841.8%21,99743.7%105,64438.1%98,82944.6%10,65859.5%Race/Ethnicity White376,37266.4%26,27352.2%181,89265.6%155,68770.3%12,52069.9% Black51,7579.1%35027.0%23,2488.4%22,96710.4%204011.4% Hispanic37,9826.7%44998.9%19,7797.1%12,7495.8%9555.3% Asian14,6752.6%21274.2%81032.9%42281.9%2171.2% Other51560.9%4200.8%24870.9%21351.0%1140.6% Unknown80,85514.3%13,46426.8%41,64715.0%23,68710.7%205711.5%Dyspnea No535,79894.5%50,04999.5%270,90497.7%200,91390.7%13,93277.8% At Rest15170.3%120.0%2260.1%9540.4%3251.8% Moderate Exertion29,4825.2%2240.4%60262.2%19,5868.8%364620.4%Diabetes No484,62085.5%50,08599.6%257,65593.0%165,45874.7%11,42263.8% Non-Insulin54,4279.6%1590.3%15,5015.6%35,76716.2%300016.8% Insulin27,7504.9%410.1%40001.4%20,2289.1%348119.4%Sepsis None564,73699.6%50,17699.8%276,36999.7%220,45499.5%17,73799.1% Any Sepsis3380.1%140.0%1260.0%1670.1%310.2% Septic Shock100.0%10.0%00.0%60.0%30.0% SIRS^b^17130.3%940.2%6610.2%8260.4%1320.7%Functional Status Independent561,05099.0%50,23899.9%276,13399.6%217,68098.3%16,99995.0% Partially Dependent53210.9%470.1%9760.4%34841.6%8144.5% Totally Dependent4260.1%00.0%470.0%2890.1%900.5%Steroid Use No547,93296.7%50,11499.7%271,01597.8%210,23694.9%16,56792.5% Yes18,8653.3%1710.3%61412.2%11,2175.1%13367.5%Hypertension with Medications No312,61855.2%49,34498.1%183,33166.1%76,34534.5%359820.1% Yes254,17944.8%9411.9%93,82533.9%145,10865.5%14,30579.9%Dialysis No562,08999.2%50,284100.0%277,01199.9%218,79498.8%16,00089.4% Yes47080.8%10.0%1450.1%26591.2%190310.6%COPD^c^ No544,43996.1%50,25299.9%274,21698.9%205,48392.8%14,48880.9% Yes22,3583.9%330.1%29401.1%15,9707.2%341519.1%Ascites No565,88599.8%50,278100.0%276,93099.9%220,87899.7%17,79999.4% Yes9120.2%70.0%2260.1%5750.3%1040.6%Congestive Heart Failure (CHF) No564,69199.6%50,282100.0%277,071100.0%220,21099.4%17,12895.7% Yes21060.4%30.0%850.0%12430.6%7754.3%Renal Failure No566,31199.9%50,283100.0%277,127100.0%221,18599.9%17,71699.0% Yes4860.1%20.0%290.0%2680.1%1871.0%Disseminated Cancer No555,76998.1%50,21199.9%274,28499.0%214,08696.7%17,18896.0% Yes11,0281.9%740.1%28721.0%73673.3%7154.0%Smoker No469,38082.8%46,06091.6%230,44183.1%179,15580.9%13,72476.7% Yes97,41717.2%42258.4%46,71516.9%42,29819.1%417923.3%Wound Infection No559,37598.7%50,09499.6%275,49299.4%217,01498.0%16,77593.7% Yes74221.3%1910.4%16640.6%44392.0%11286.3%Weight Loss No561,76699.1%50,21499.9%275,68899.5%218,31198.6%17,55398.0% Yes50310.9%710.1%14680.5%31421.4%3502.0%Bleeding Disorder No551,78497.4%50,19999.8%274,97099.2%210,95095.3%15,66587.5% Yes15,0132.6%860.2%21860.8%10,5034.7%223812.5%Transfusion No566,32299.9%50,276100.0%277,01599.9%221,19499.9%17,83799.6% Yes4750.1%90.0%1410.1%2590.1%660.4%Ventilator No566,764100.0%50,284100.0%277,151100.0%221,433100.0%17,896100.0% Yes330.0%10.0%50.0%200.0%70.0%^a^*ASA-PS* American Society of Anesthesiologists Physical Status, ^b^*SIRS* Systemic inflammatory response syndrome, ^c^*COPD* Chronic obstructive pulmonary disease Table 3Surgery Characteristics of Study SampleAllASA-PS 1ASA-PS 2ASA-PS 3ASA-PS 4no.%no.%no.%no.%no.%*n=*566,79750,2858.9%277,15648.9%221,45339.1%17,9033.2%CPT^a^ by Body System Digestive System202,26835.7%17,59735.0%95,98434.6%83,51037.7%517728.9% Musculoskeletal System133,23023.5%13,51826.9%69,32025.0%48,19721.8%219512.3% Integumentary System55,6569.8%683713.6%31,58211.4%16,4227.4%8154.6% Female Genital System51,0679.0%621112.4%32,05511.6%12,4335.6%3682.1% Cardiovascular System33,2815.9%9822.0%42861.5%21,3819.7%663237.0% Nervous System24,4404.3%13992.8%12,1144.4%10,3224.7%6053.4% Urinary System23,2204.1%8241.6%96063.5%11,8475.3%9435.3% Endocrine System20,9933.7%12942.6%12,2644.4%70093.2%4262.4% Male Genital System10,1731.8%9541.9%58092.1%33031.5%1070.6% Respiratory System67051.2%650.1%14600.5%46842.1%4962.8% Hemic/lymphatic System31300.6%1180.2%13920.5%15490.7%710.4% Auditory System16990.3%4420.9%9560.3%2910.1%100.1% Mediastinum/Diaphragm8210.1%120.0%2500.1%5010.2%580.3% Maternity Care/Delivery1020.0%240.0%740.0%40.0%00.0% Reproductive System/Intersex120.0%80.0%40.0%00.0%00.0% General00.0%00.0%00.0%00.0%00.0% Eye/Ocular Adnexa00.0%00.0%00.0%00.0%00.0%Top 10 CPT CCS^b^ *Other*165,71529.2%17,76935.3%69,83325.2%69,03231.2%908150.7% Other hernia repair45,0577.9%45799.1%23,1838.4%16,4447.4%8514.8% Arthroplasty knee39,1556.9%9411.9%19,3917.0%18,1928.2%6313.5% Hysterectomy, abdominal and vaginal37,8376.7%39897.9%24,0258.7%95324.3%2911.6% Colorectal resection32,8515.8%8911.8%15,9745.8%15,0976.8%8895.0% Inguinal and femoral hernia repair26,8814.7%49609.9%15,0555.4%64012.9%4652.6% Cholecystectomy26,5534.7%32826.5%15,7915.7%71113.2%3692.1% Gastric bypass24,6794.4%1100.2%68902.5%17,0917.7%5883.3% Hip replacement24,0944.3%9641.9%13,1234.7%95564.3%4512.5% Lumpectomy22,1003.9%27745.5%12,9134.7%61572.8%2561.4%^a^*CPT* Current Procedural Terminology, ^b^Clinical Classification Software

Development and concurrent validation of a model to predict ASA-PS {#Sec15}
------------------------------------------------------------------

Additional file [1](#MOESM1){ref-type="media"}: Table S1 describes the details of our multinomial model with ASA-PS as an outcome. Across all ASA categories, conditions such as age, gender, race, or BMI were weakly predictive. However, conditions strongly predictive of ASA-PS status included total functional dependence, use of dialysis, insulin-dependent diabetes, disseminated cancer, COPD, hypertension treated with medications, and use of steroids.

Upon internal cross-validation, the overall C-statistic for the multinomial model (preoperative variables predicting observed ASA status) was C = 0.77 (95% CI: 0.766--0.773), signifying very good congruence between predicted and observed ASA status. The predicted ASA status agreed with the observed ASA-PS status for 99% of cases by one level (higher or lower) for ASA-PS 1--3 and for 85% for ASA-PS 4. In general, our model tended to upgrade observed ASA I's to predicted ASA-PS II's. At the same time the model tended to downgrade observed ASA-PS IV's to predicted ASA-PS III's and V's to IV's and III's. This compression was most marked for observed ASA-PS IV. Preoperative factors associated with outliers for predicted ASA status revealed that in general discordances were found with extremes of age and BMI; procedures for musculoskeletal, nervous, and cardiovascular system CPT classes; and with diagnoses such as diabetes. In terms of concurrent validity, the group with predicted ASA-PS \> observed ASA-PS had more comorbidities than patients with predicted ASA-PS \< observed ASA-PS (mean 1.0 vs. 0.84, *p* \< 0.001), higher BMI (30.7 vs. 29.6, *p* \< 0.001), and a trend toward more functional limitations (98.95% independent vs. 99.03% independent, *p* = 0.067).

Assessing the predictive validity of the ASA-PS model {#Sec16}
-----------------------------------------------------

Using unadjusted, predicted ASA status to predict 30-day postoperative outcomes (predictive validity), the C-statistics ranged from 0.57--0.73 with mortality at 0.73 (95% CI: 0.719--0.740, Fig. [2](#Fig2){ref-type="fig"}). In comparison, using observed ASA status alone the C-statistics ranged from 0.58--0.76 with mortality at 0.73 (95% CI: 0.719--0.740). The multivariable models (that included adjustment factors such as anesthesia type and operation time) increased the ability of the models to discriminate for the various outcomes with covariates explaining some of the variance in outcomes (Fig. [3](#Fig3){ref-type="fig"}). Higher C-statistics were noted for individual complications (i.e.,sepsis,renal insufficiency) vs. the category of any complication. Patients with predicted ASA-PS \> observed ASA-PS had a lower proportion of complications (3.4% vs 6.7%, *p* \< 0.001) and lower mortality (0.13% vs 0.41%, *p* \< 0.001). Fig. 2C-Statistics for Post-Operative Outcomes (Unadjusted) Fig. 3C-Statistics for Post-Operative Outcomes (Adjusted)

**Online risk calculator:** The online calculator may be accessed at <https://s-spire-clintools.shinyapps.io/ASA_PS_Estimator/>

Discussion {#Sec17}
==========

Our objective was to develop a model for predicting ASA-PS status using a wide range of preoperative predictors. We assessed both the concurrent and the predictive validity of predicted ASA-PS relative to observed ASA-PS and a variety of outcomes including 30-day morbidity and mortality. We noted that predicted ASA-PS was more closely associated with key indicators of preoperative status including comorbidities and higher BMI with a trend towards functional status compared to observed ASA-PS on. The overall accuracy (C = 0.77) of our model was comparable to measurements of inter-rater reliability found when anesthesiologists evaluated preoperative physical status \[[@CR2], [@CR24]--[@CR27]\]. Our study further highlights the advantages and challenges of using entirely preoperative data for risk calculation, especially as surgical risk models continue to be built \[[@CR7], [@CR8]\].

The ability to have an electronically derived measure of ASA-PS can potentially assist with research, quality measurement, resource allocation, and clinical applications. Studies indicate that higher ASA-PS patients can experience increased morbidity and mortality, higher rates of hospital readmissions, and costs when undergoing ambulatory surgery procedures \[[@CR28]--[@CR30]\]. With the aim of lowering surgical risks and improving patient outcomes, ASA-PS is increasingly being used by government bodies and insurance agencies to justify the need for hospital inpatient admission either for pre- or post-operative management \[[@CR31], [@CR32]\]. For example, preoperative hospital admission may be necessary for optimization of comorbidities like congestive heart failure; a postoperative admission instead may be indicated to avoid physiologic deterioration or to maintain functional status in the setting of surgical trauma. While observed ASA-PS correlated more strongly with 30-day outcomes than predicted ASA-PS in our study, predicted ASA-PS values could be useful in situations where a pre-populated estimate in an EHR is needed (see Shiny application) or in studies where some or all cases are missing ASA-PS values \[[@CR33]\]. Alignment of provider or facility decisions with government or payor guidelines can then be evaluated post-hoc for sample stratification where ASA-PS is missing and for quality monitoring. Calculation of a predicted ASA-PS could also aid in care coordination at the time of initial preoperative evaluation \[[@CR5], [@CR7], [@CR14], [@CR34]\]. Guidelines suggest that non-anesthesia clinicians when faced with the need to provide moderate or deep sedation for ASA-PS III or IV should have an anesthesia clinician present to avoid adverse outcomes such as respiratory arrest \[[@CR35]\]. An automated process for calculating ASA-PS may therefore be helpful in generating electronic prompts and reminders.

Our study extends methods and results by Davenport et al. that evaluated the relationship between predicted ASA-PS, other preoperative risk factors, and 30- day morbidity and mortality outcomes \[[@CR36]\]. While our study was a national level sample, Davenport's study used National Surgical Quality Improvement Project data for 5878 surgical patients at a university medical center; they similarly noted that observed ASA-PS was a stronger predictor of 30-day outcomes than predicted ASA-PS. A potential explanation for these types of discordances is that ASA-PS remains a subjective measure of disease status and prone to differences in opinion when offered discrete categories (i.e.1,2). While the discrimination of our multivariable adjusted models in predicting 30-day outcomes was better than with univariate models, our results like Davenport's suggest the further need for intraoperative variables and facility level data for risk adjustment. The fact that observed ASA-PS correlated more strongly with 30-day outcomes than predicted ASA --PS may reflect the fact that there are other confounding variables that still need to be accounted for in our predictive model. A prominent category of variables that we were unable to include was patients' preoperative laboratory data; laboratory data was found to be not missing at random (NMAR) in our sample. In their predictive model for ASA-PS, Davenport et al. found that laboratory measures such as low serum albumin, high white blood cell count, and low hematocrit were strong predictors of 30-day outcomes \[[@CR36]\]. The ability to include preoperative laboratory data could further strengthen the predictive validity of our model.

Limitations and strengths {#Sec18}
-------------------------

Given that our study involved the use of preexisting data, there are certain limitations and strengths. The analysis of preexisting data is always limited by its extant quality, the type of elements that it collects and the number of facilities. However, our study sample was a national cohort drawn from a broad variety of facilities across a wide geographic distribution. We also evaluated multiple sociodemographic criteria along with detailed clinical data and administrative data to enhance external validity. Another potential limitation is that while the ACS-NSQIP data set captures a wide variety of cases, nevertheless, it is still not 100% case capture. Nevertheless, our sample included a diverse set of procedures with detailed clinical data and administrative data that enhanced the concurrent validity of our models. As a national, clinical registry, the ACS-NSQIP is bound to contain some level of error or inconsistency. We attempted to exclude patients with a preoperative stay due to concerns that a preoperative stay might indicate the presence of conditions (like myocardial infarction) or events (need for preoperative optimization) that might enter into determination of ASA-PS. In addition, these conditions may not necessarily be observable through the ACS-NSQIP database. However, even with this exclusion, a very small number of patient with other indicators suggesting a preoperative stay, such as the 33 patients (out of the total sample of 566,797) who were on a ventilator in the 48 h prior to surgery, were not excluded. Given the very rare nature of these apparent errors or inconsistencies, we maintain that any potential bias would be negligible.

Conclusions {#Sec19}
===========

The ability to have an electronically-derived measure of ASA-PS can assist with resource allocation and quality measurement as well as care coordination \[[@CR33]\].. The model- based approach demonstrated here appears to be equal to or more valid than existing holistic judgments. An important key challenge is to demonstrate how these automatic approaches might be accepted by clinicians and actually add value. It has been widely published in the decision making literature that statistical models outperform crude judgments \[[@CR37]\]. The original ASA-PS score, despite being a 'quick-and-dirty' tool, is easy to use and easy to apply. Approaches that combine subjective judgments and objective information may outperform both and should be evaluated as part of an implementation study. In addition, by enabling the prediction of ASA-PS when it is not available and potentially improving the measure's accuracy when ASA-PS is available, we also see our effort as an aid for other researchers and clinicians to build better risk prediction models. Further external validation of this model with non-ACS-NSQIP data will help define the minimal number of elements needed to predict ASA-PS and further refine predictive ability \[[@CR26], [@CR38], [@CR39]\].
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**Additional file 1:** **Table S1.** Coefficients for the Multinomial Model to Predict ASA Class by Major Pre-operative Factors.

ACS NSQIP

:   American College of Surgeons National Surgical Quality Improvement Program

ASA-PS

:   American Society of Anesthesiologists Physical Status Classification system

BMI

:   Body mass index

CCS

:   Clinical Classification Software

MAC

:   Monitored anesthesia care

PUF

:   Participant Use File

SIRS

:   Systemic inflammatory response syndrome

**Publisher's Note**

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information
=========================

**Supplementary information** accompanies this paper at 10.1186/s12913-019-4640-x.

None.

Every author below is has made substantial contributions to the conception and design of the work; the analysis and interpretation of data; has drafted the work or substantively revised it; and has approved the submitted version; has agreed both to be personally accountable for the author's own contributions and to ensure that questions related to the accuracy or integrity of any part of the work, even ones in which the author was not personally involved, are appropriately investigated, resolved, and the resolution documented in the literature. All authors read and approved the final manuscript. Authors: SCM; SP; TB; RK; EDS; AKF; DE; MH; YW; AWT;ERM,AHS

This work was funded by grants from the VA HSR&D Service (IIR 16--216; RCS14--232). The funding body had no role in the design of the study and data collection, analysis, and interpretation of data and in writing of the manuscript.

Our data source was the 2014 Participant Use File (PUF) of the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP), which is available to member institutions.

We used publically available registry data from the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) program. The de-identified dataset does not contain any data or code or link that could allow identification of the individual. As defined by federal regulations, 45 CFR 46.102, this is not deemed human subject research and exempt from IRB review and informed consent.

Not applicable.

The authors declare that they have no competing interests.
